Environmental Sustainability Green Toolkit
ISOPP aims to lead the transition toward climate-resilient, sustainable pharmacy practices, particularly in oncology pharmacy. Aligned with this mission, the Environmental Sustainability Task Force has developed an Environmental Sustainability Green Toolkit to provide the global oncology pharmacy community with tools and resources to identify opportunities for sustainable practices.
Information shared includes (i) an overview of sustainable pharmacy practices and the role of pharmacists, (ii) relevant position statements, presentations and publications by the ISOPP community, (iii) tools and toolkits to assist implementation of sustainable pharmacy practices and (iv) focused topics covering dose banding and dose rounding, vial sharing, and deprescribing. Visit each category below to view the relevant resources.
You do not have permission to view this content. Please log in or join ISOPP for access.
- Fahrenbruch R, Kintzel P, Bott AM, et al. Dose rounding of biologic and cytotoxic anticancer agents: A position statement of the Hematology/Oncology Pharmacy Association. J Oncol Pract. 2018 Mar;14(3):e130-e136.
- National Health Service (NHS). National dose banding tables.
- British Columbia Cancer Agency (BCCA). Pharmacy FAQ dose banding. Community Oncology Pharmacy Educators March 2023.
- British Columbia Cancer Agency (BCCA). Dose banding tables. Revised 1 April 2026.
- Van Huet AGC, Fiebrich-Westra H-B, Nygard P, et al. Optimizing chemotherapy practices: The impact of dose banding on reissuing and waste reduction. Journal of Oncology Pharmacy Practice 2025; https://doi.org/10.1177/10781552251370560.
- De Souza Marques IJ, de Albuquerque Almeida VEG and de Lima EN. Retrospective analysis of the dose banding technique in a public hospital in the Agreste of Pernambuco. Rev. Bras. Cancerol. 2025;71(4): https://doi.org/10.32635/2176-9745.RBC.2025v71n4.5177EN.
- El Baraka S, Chefchaouni AC, Bourdaime A, et al. Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology. J Oncol Pharm Pract. 2024;30(7):1152-59.